Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial

Abstract The authors evaluated the efficacy, safety, and characteristics of patients who respond well to standard dose triple combination therapy including chlorthalidone 25 mg with telmisartan 80 mg plus amlodipine 5 mg in hypertensive patients. This is a multicenter, double‐blind, active‐controlle...

Full description

Bibliographic Details
Main Authors: Eun Joo Cho, Moo Hyun Kim, Young‐Hak Kim, Kiyuk Chang, Dong‐Ju Choi, Woong Chol Kang, Jinho Shin, Seong Hwan Kim, Namho Lee, Jang Won Son, Joon‐Hyung Doh, Woo‐Shik Kim, Soon Jun Hong, Moo‐Yong Rhee, Youngkeun Ahn, Sang‐Wook Lim, Seung Pyo Hong, So‐Yeon Choi, Min Su Hyon, Jin‐Yong Hwang, Kihwan Kwon, Kwang Soo Cha, Sang‐Hyun Ihm, Jae‐Hwan Lee, Byung‐Su Yoo, Hyo‐Soo Kim
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:The Journal of Clinical Hypertension
Subjects:
Online Access:https://doi.org/10.1111/jch.14707